These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2944606)

  • 1. Different characteristics of allogeneic and trinitrophenyl-modified H-2-restricted cell-mediated lympholysis: analysis of differences in interleukin-2 dependency using an ontogenical approach.
    Gondo H; Tokuda N; Tanaka K; Nomoto K
    Cell Immunol; 1986 Jul; 100(2):422-33. PubMed ID: 2944606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-mediated lympholysis (CML) to allogeneic and trinitrophenyl (TNP)-modified cells: re-evaluation of the role of the thymus in CML.
    Gondo H; Tokuda N; Taniguchi K; Nomoto K
    J Clin Lab Immunol; 1985 Jul; 17(3):131-6. PubMed ID: 2931532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human lymphokine-activated killer cell system. V. Purified recombinant interleukin 2 activates cytotoxic lymphocytes which lyse both natural killer-resistant autologous and allogeneic tumors and trinitrophenyl-modified autologous peripheral blood lymphocytes.
    Grimm EA; Wilson DJ
    Cell Immunol; 1985 Sep; 94(2):568-78. PubMed ID: 3928175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell responses induced by the parenteral injection of antigen-modified syngeneic cells. II. Mechanisms, specificity, and cellular analysis of 2,4,6-trinitrophenol (TNP)-specific cytolytic response priming by intravenous versus subcutaneous injection with TNP-modified syngeneic cells.
    Miller SD; Butler LD; Cleveland RP; Moorhead JW; Claman HN; Chiller JC
    Cell Immunol; 1983 Dec; 82(2):378-93. PubMed ID: 6197193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H-2 homology requirements for secondary cell-mediated lympholysis and miced lymphocyte reactions to TNP-modified syngeneic lymphocytes.
    Schmitt-Verhulst AM; Garbarino CA; Shearer GM
    J Immunol; 1977 Apr; 118(4):1420-7. PubMed ID: 66294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of lymphokine-activated killer cells induced by IL-2. Separate lymphoid subpopulations lyse tumor, allogeneic blasts, and modified syngeneic blasts.
    LeFor AT; Eisenthal A; Rosenberg SA
    J Immunol; 1988 Jun; 140(11):4062-9. PubMed ID: 3259603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal cell-induced generation of cytotoxic T-lymphocyte responses against alloantigens or TNP-modified syngeneic cells: requirement for Ia-positive Langerhans cells.
    Pehamberger H; Stingl LA; Pogantsch S; Steiner G; Wolff K; Stingl G
    J Invest Dermatol; 1983 Sep; 81(3):208-11. PubMed ID: 6604111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic T lymphocyte responses in allogeneic radiation bone marrow chimeras. The chimeric host strictly dictates the self-repertoire of Ia-restricted T cells but not H-2K/D-restricted T cells.
    Bradley SM; Kruisbeek AM; Singer A
    J Exp Med; 1982 Dec; 156(6):1650-64. PubMed ID: 6217271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed lymphocyte reactivity and cell-mediated lympholysis to trinitrophenyl-modified autologous lymphocytes in C57BL/10 congenic and B10-A recombinant mouse strains.
    Shearer GM; Lozner EC; Rehn TG; Schmitt-Verhulst AM
    J Exp Med; 1975 Apr; 141(4):930-4. PubMed ID: 123935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic control of cell-mediated lympholysis to trinitrophenyl (TNP)-modified murine syngeneic cells. I. Expression of Ir gene function at the Cytotoxic precursor and helper cell levels in the response to TNP-H-2 b self.
    Fujiwara H; Shearer GM
    J Immunol; 1981 Mar; 126(3):1047-51. PubMed ID: 6780621
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on in-vivo priming of the trinitrophenyl-reactive cytotoxic effector-system. III. Are helper T cells involved in the in-vitro generation of cross-reactive as well as restricted cytotoxic responses?
    Fujiwara H; Levy RB; Shearer GM
    Immunobiology; 1982 Feb; 160(5):472-8. PubMed ID: 6978282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helper cells in the autologous mixed lymphocyte reaction. I. Generation of cytotoxic T cells recognizing modified self H-2.
    Wolos JA; Smith JB
    J Immunol; 1981 Aug; 127(2):711-5. PubMed ID: 6454726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance to Mls-disparate cells induces suppressor T cells that act at the helper level to prevent in vivo generation of cytolytic lymphocytes to hapten-altered self.
    Vargo PM; Battisto JR
    J Immunol; 1984 Jun; 132(6):2796-801. PubMed ID: 6233362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of shared H-2Kk and H-2Dk antigens that function as self determinants for cell-mediated lympholysis to trinitrophenyl-self.
    Fujiwara H; Levy RB; Shearer GM
    J Immunol; 1981 Apr; 126(4):1522-5. PubMed ID: 6162891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of cytotoxic T lymphocytes from thymocyte precursors to trinitrophenyl-modified self antigens. I. Requirement of both killer-helper factor(s) and interleukin 2 for CTL generation from a subpopulation of thymocytes.
    Takatsu K; Kikuchi Y; Kanatani T; Okuno K; Hamaoka T; Tominaga A; Sano Y
    J Immunol; 1986 Feb; 136(4):1161-70. PubMed ID: 3080519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell-mediated cytotoxicity against trinitrophenyl-modified cells: effect of glutaraldehyde treatment on the immunogenicity and antigenicity of trinitrophenyl-modified cells.
    Forman J
    J Immunol; 1977 May; 118(5):1755-62. PubMed ID: 404357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trinitrophenyl modification of H-2k and H-2b spleen cells results in enhanced serological detection of Kk-like determinants.
    Levy RB; Dower SK; Shearer GM; Segal DM
    J Exp Med; 1984 May; 159(5):1464-72. PubMed ID: 6201586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and characterization of T-cell clones specific for trinitrophenyl (TNP)-modified syngeneic spleen cells (TNP-self).
    Arora PK; Hanna EE
    Indian J Exp Biol; 1989 Oct; 27(10):843-8. PubMed ID: 2483952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymus cells suppress the in vitro cytotoxic response against trinitrophenyl (TNP) modified syngeneic cells.
    Hurme M; Bång BE
    Scand J Immunol; 1981; 13(1):35-40. PubMed ID: 6972089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced TNP-reactive helper T cell activity and its utilization in the induction of amplified tumor immunity that results in tumor regression.
    Fujiwara H; Moriyama Y; Suda T; Tsuchida T; Shearer GM; Hamaoka T
    J Immunol; 1984 Mar; 132(3):1571-7. PubMed ID: 6198397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.